Coronary Heart Disease Complicated with Insomnia
Conditions
Interventions
Experimental group:The observation group was administered auricular point pressing therapy for 4 weeks on the basis of TCM syndrome differentiation, with treatment given every other day and bilateral
Control group:The control group received sleep hygiene education as the main intervention, with pharmacotherapy administered when necessary: Eszopiclone Tablets 1–3 mg per day.
Sponsors
The Third People's Hospital of Datong
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Aged = 18 years old and = 80 years old 2.Patients who are clearly diagnosed with short-term or chronic insomnia with reference to Guidelines for the Diagnosis and Treatment of Insomnia in Chinese Adults (2017 Edition) 3.Patients who are clearly diagnosed with coronary atherosclerotic heart disease 4.Patients who agree to participate in this study and sign the informed consent form
Exclusion criteria
Exclusion criteria: 1.Patients who are currently taking hypnotic drugs or have taken such drugs, or received other sleep-improving therapies within the past month. 2.Patients complicated with severe mental disorders. 3.Pregnant or lactating women. 4.Patients complicated with other severe diseases (e.g., malignant tumors) and with an expected survival time of less than 1
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pittsburgh Sleep Quality Index (PSQI) ; Seattle Angina Questionnaire (SAQ);Generalized Anxiety Disorder 7 (GAD-7);Serum 5-hydroxytryptamine (5-HT);Norepinephrine (NE);Brain-Derived Neurotrophic Factor(BDNF); | — |
Countries
China
Contacts
Public Contacthaofei zheng
The Third People's Hospital of Datong
Outcome results
None listed